Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey J. Abrams currently holds 45,927 shares of Imprimis Pharmaceuticals, Inc. (IMMY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey J. Abrams has been a net neutral trader of IMMY stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey J. Abrams's most recent insider trade was on Jun 27, 2013, when they sold 6,865 shares at $0.00 per share.
Jeffrey J. Abrams serves as Executive at Imprimis Pharmaceuticals, Inc. (IMMY). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Jeffrey J. Abrams holds the position of Executive at Imprimis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Jeffrey J. Abrams has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jeffrey J. Abrams was on Jun 27, 2013, when they purchased $0 worth of IMMY shares. This transaction involved 6,865 shares at N/A per share.
Jeffrey J. Abrams currently owns 45,927 shares of Imprimis Pharmaceuticals, Inc. (IMMY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey J. Abrams's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey J. Abrams has 1 Form 4 filings on record as an insider at Imprimis Pharmaceuticals, Inc..
Set alerts for Jeffrey J. Abrams and 40,000+ other insiders.